NCT06353087Completed
Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
THE REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN MODERATE-TO-SEVERE ATOPIC DERMATITIS (AD) PATIENTS RECEIVING ABROCITINIB
Source: ClinicalTrials.gov · Last updated 18 Aug 2026
Brief summary (registry, in English)
This study is to describe the real-world treatment patterns and clinical outcomes in moderate-to-severe AD patients receiving abrocitinib over a 12-month observation period, and to describe patient demographic and baseline characteristics.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 41 (actual)
- First submitted
- 21 Mar 2024
- Start date
- 19 Jun 2024
- Primary completion date
- 22 Jun 2026
- Lead sponsor
- Pfizer
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06353087
What you commit to
- Study type: Observational
- Participants enrolled: 41
- From 19 Jun 2024 to the primary completion date, 22 Jun 2026
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Any prior use of abrocitinib
- Simultaneous participation in a study that includes administration of any investigational drug or procedure
Other
- Patients meeting any of the following criteria will not be included in the study:
Who the study is looking for
- Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
- Patients aged ≥12 years
- Patients with confirmed diagnosis of moderate-to-severe AD as assessed by the physician
- Patients for whom the physician's decision has been made to newly prescribe abrocitinib in usual clinical practice conditions
- Evidence of a personally signed and dated informed consent/assent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chang Gung Memorial Hospital at Kaohsiung Coordinator of this site? Confirm its status | Kaohsiung City | Taiwan | Unknown status |
| Kaohsiung Medical University Hospital Coordinator of this site? Confirm its status | Kaohsiung City | Taiwan | Unknown status |
| Taipei Medical University Shuang Ho Hospital Coordinator of this site? Confirm its status | New Taipei City | Taiwan | Unknown status |
| Taipei Veterans General Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| MacKay Memorial Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| Tri-Service General Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| NTUH Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| Chang Gung Hospital Linkou Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.